BA

Healthcare · Pharmaceuticals

Bafna Pharmaceuticals Ltd (BAFNAPH)

₹469.95

Mkt cap
₹1,111 Cr
P/E ratio
96.40
P/B
10.78
Div yield
0.00%
ROE
12.30%
ROCE
11.90%
EPS (TTM)
₹4.88
Book value
₹44
52W range
95–502
Sector
Healthcare

Price history

Previous close

Incorporated in 1981, Bafna Pharmaceuticals Ltd manufactures finished pharmaceutical formulations [1]

NSE BAFNAPHBSE 532989
Health check
Cautious
ValuationExpensive
ProfitabilityAverage
GrowthLow
TechnicalsBullish
52-week range
−6.32% from high
₹470
₹95+395.88% from low₹502
Current
₹469.95
Prev close
₹479.50
Day
−1.99%
Price performance
1D
−1.99%
1W
−2.51%
1M
+3.98%
3M
+97.71%
6M
+245.96%
1Y
+159.40%
YTD
+210.92%

Financials

Revenue, profit & margin
P/E ratio
96.4×
BAFNAPH is 197% above the sector median of 32.5×
BAFNAPH96.4×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales40.6828.4441.4033.2940.3233.1939.0634.6235.4738.2942.2426.5847.67
YoY Sales growth+85.25%-16.89%-1.99%-20.64%-0.88%+16.70%-5.65%+4.00%-12.03%+15.37%+8.14%-23.22%+34.40%
Expenses36.6730.5138.5132.0836.5330.1335.9529.5531.1935.2438.6925.6939.06
Operating Profit4.01-2.072.891.213.793.063.115.074.283.053.550.898.61
OPM %9.86%-7.28%6.98%3.63%9.40%9.22%7.96%14.64%12.07%7.97%8.40%3.35%18.06%
Other Income0.160.980.520.161.020.18-0.760.601.181.221.761.911.13
Interest0.440.580.680.650.620.640.820.910.860.861.030.941.02
Depreciation1.241.271.271.441.581.660.221.371.471.571.661.781.87
Profit before tax2.49-2.941.46-0.722.610.941.313.393.131.842.620.086.85
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-4.96%0.00%0.00%
Net Profit2.48-2.941.46-0.722.620.951.313.393.121.842.750.086.85
EPS in Rs1.05-1.240.62-0.301.110.400.551.431.320.781.160.032.90
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −0.00% · closed higher next day 0 of last 2
 Q1FY27Q2FY27
Broadcast11 Aug '26◦11 Nov '26◦
Earnings day−1.99%+1.99%
+1 day−3.95%−0.04%
+5 days−11.40%−0.57%
+15 days+12.51%—
+30 days+25.37%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
75.00%Promoter
Promoters75.00%
FIIs9.34%
Public15.66%
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.704,51,5380.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.071,78,1800.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.691,24,1950.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.481,19,9900.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.561,16,3600.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.881,14,5180.92%852−35.05%7,404−2.44%15.49%
Bafna Pharma.₹469.9596.441,1110.00%7+119.55%48+34.40%11.87%
Median: 160 Co.₹432.2032.471,9870.08%13+33.73%179+21.23%14.94%

Filings